Related Experiment Video
Updated: Jun 4, 2026
12:14
CAM-Delam Assay to Score Metastatic Properties by Quantifying Delamination and Invasion Capacity of Cancer Cells
Published on: June 2, 2022
The galanin system in cancer.
1Department of Pediatrics, SALK and Paracelsus Medical University, Müllner Hauptstrasse 48, 5020 Salzburg, Austria.
Experientia Supplementum (2012)
|February 9, 2011
Summary
Galanin (a neuropeptide) and its receptors are found in various cancers, offering potential for new cancer diagnostics and treatments. Research explores their dual role in tumour growth and inhibition.
Area of Science:
- Oncology
- Neuroendocrinology
- Molecular Biology
Background:
- Neuropeptides and their receptors are expressed in neuroendocrine and non-neuroendocrine cancers.
- These molecules offer potential for targeted cancer diagnosis and therapy using peptide analogues.
- Galanin, a neuropeptide, has diverse physiological roles and is detected in numerous cancer types.
Purpose of the Study:
- To investigate the role of galanin and its receptors (GalR1, GalR2, GalR3) in various cancers.
- To explore the potential of galanin and its receptors as diagnostic and therapeutic targets.
- To understand the dual effects of galanin on tumour proliferation.
Main Methods:
- Review of studies detecting galanin peptide and receptor expression in different cancers.
- Analysis of correlations between galanin/receptor expression and tumour characteristics.
- Examination of galanin's effects on tumour growth in preclinical models and cell cultures.
Main Results:
- Galanin peptide and its receptors (GalR1, GalR2, GalR3) are expressed in various cancers, including pheochromocytoma, melanoma, and breast cancer.
- Expression levels correlate with tumour stage and subtypes in certain cancers.
- Galanin exhibits both tumour-reducing and tumour-promoting effects, depending on the context and receptor activation (GalR1 generally anti-proliferative, GalR2 mixed effects).
Conclusions:
- Galanin and its receptors represent promising molecular targets for cancer diagnosis and therapy.
- The complex, context-dependent effects of galanin on tumour growth warrant further investigation for therapeutic development.
- Targeting galanin signalling pathways could lead to novel anti-cancer strategies.
Related Concept Videos
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
01:41Non-Canonical Wnt Signaling Pathways
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
02:54Canonical Wnt Signaling Pathway
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...